PDS Biotechnology Corporation (PDSB)
Nasdaq: PDSB · Pharmaceutical Preparations · Princeton, NJ · filing with the SEC since 2009
Filings
450 filings since 2017 beside 219 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed Jun 26, 2026.
Filings a yearinsider forms included
8985556469415967
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Oct 20, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Jul 31, 2026.SEC letters: 4 in the last 36 months, the newest Apr 24, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 20, 2026
8-K items 5.02, 8.01, 9.01
Officer or director change; Other event · Current report
Oct 18, 2026
Sep 14, 2026
8-K items 1.02, 5.02, 7.01, 8.01, 9.01
Major agreement ended; Officer or director change; Investor disclosure (Regulation FD); Other event · Current report
Sep 12, 2026
Sep 8, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Sep 7, 2026
Sep 4, 2026
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Aug 31, 2026
Aug 25, 2026
8-K items 2.05, 5.02
Exit or restructuring costs; Officer or director change · Current report
Aug 21, 2026
Aug 14, 2026
8-K items 5.03, 5.07, 9.01
Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Aug 10, 2026
Jun 15, 2026
8-K items 1.01, 1.02, 2.03, 3.02, 3.03, 9.01
Major agreement signed; Major agreement ended; New debt or obligation taken on; Shares sold without registration; Change to shareholders' rights · Current report
May 1, 2026
8-K items 1.01, 1.02, 2.03, 3.02
Major agreement signed; Major agreement ended; New debt or obligation taken on; Shares sold without registration · Current report
Apr 30, 2026
40 of 450 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.